EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

O -Mucin-degrading carbohydrate-active enzymes and their possible implication in inflammatory bowel diseases

Aurore Labourel, Jean-Luc Parrou, Céline Deraison, Muriel Mercier-Bonin, Sophie Lajus, Gabrielle Potocki-Veronese iD

Essays in Biochemistry · 2023-04-18 · 67 (3) · 331-344

DOI: 10.1042/ebc20220153 ↗

At a glance

Übersichtsarbeit in Essays in Biochemistry, published online on 2023-04-18. Written by Aurore Labourel and 5 co-authors. Institution: TBI, Université de Toulouse, CNRS, INRAE, INSA, Toulouse, France. Major MEDLINE topics: Mucins, Inflammatory Bowel Diseases. Cited 31 times so far (Crossref); 104 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Inflammatory bowel diseases (IBD) are modern diseases, with incidence rising around the world. They are associated with perturbation of the intestinal microbiota, and with alteration and crossing of the mucus barrier by the commensal bacteria that feed on it. In the process of mucus catabolism and invasion by gut bacteria, carbohydrate-active enzymes (CAZymes) play a critical role since mucus is mainly made up by O- and N-glycans. Moreover, the occurrence of IBD seems to be associated with low-fiber diets. Conversely, supplementation with oligosaccharides, such as human milk oligosaccharides (HMOs), which are structurally similar to intestinal mucins and could thus compete with them towards bacterial mucus-degrading CAZymes, has been suggested to prevent inflammation. In this mini-review, we will establish the current state of knowledge regarding the identification and characterization of mucus-degrading enzymes from both cultured and uncultured species of gut commensals and enteropathogens, with a particular focus on the present technological opportunities available to further the discovery of mucus-degrading CAZymes within the entire gut microbiome, by coupling microfluidics with metagenomics and culturomics. Finally, we will discuss the challenges to overcome to better assess how CAZymes targeting specific functional oligosaccharides could be involved in the modulation of the mucus-driven cross-talk between gut bacteria and their host in the context of IBD.

Subjects

MeSH terms (MEDLINE)

MucinsInflammatory Bowel DiseasesHumansIntestinal MucosaCarbohydratesPolysaccharidesBacteria

Author keywords

CazymesIBDO-mucinsmetagenomicsmicrofluidics

Substances

MucinsCarbohydratesPolysaccharides

Authors and institutions

  • TBI, Université de Toulouse, CNRS, INRAE, INSA, Toulouse, France.
  • IRSD, Université de Toulouse, INSERM, INRAE, ENVT, Univ Toulouse III - Paul Sabatier (UPS), Toulouse, France.
  • Toxalim, Research Center in Food Toxicology, INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, 31000, Toulouse, France.

ORCID profiles: Gabrielle Potocki-Veronese

Cite

APA

Labourel, A., Parrou, J. L., Deraison, C., Mercier-Bonin, M., Lajus, S., & Potocki-Veronese, G. (2023). O -Mucin-degrading carbohydrate-active enzymes and their possible implication in inflammatory bowel diseases. Essays in Biochemistry, 67(3), 331-344. https://doi.org/10.1042/ebc20220153

Vancouver

Labourel A, Parrou JL, Deraison C, Mercier-Bonin M, Lajus S, Potocki-Veronese G. O -Mucin-degrading carbohydrate-active enzymes and their possible implication in inflammatory bowel diseases. Essays in Biochemistry. 2023;67(3):331-344. doi:10.1042/ebc20220153

BibTeX
@article{Labourel2023,
  author = {Labourel, Aurore and Parrou, Jean-Luc and Deraison, Céline and Mercier-Bonin, Muriel and Lajus, Sophie and Potocki-Veronese, Gabrielle},
  title = {O -Mucin-degrading carbohydrate-active enzymes and their possible implication in inflammatory bowel diseases},
  journal = {Essays in Biochemistry},
  year = {2023},
  volume = {67},
  number = {3},
  pages = {331--344},
  doi = {10.1042/ebc20220153}
}
Start for free →